(Q37939311)

25 August 2017

1 reference

title

Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia (English)

1 reference

25 August 2017

0 references

0 references

3

Mathias Fasshauer

1 reference

25 August 2017

Konstanze Miehle

1

1 reference

PubMed ID

21951069

25 August 2017

Holger Stepan

series ordinal

2

1 reference

25 August 2017

1 January 2012

1 reference

25 August 2017

Clinical Endocrinology

1 reference

25 August 2017

76

1 reference

25 August 2017

1

1 reference

25 August 2017

2-11

1 reference

What is gestational diabetes?

25 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

The known and unknown of leptin in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Expression of placental leptin and leptin receptor transcripts in early pregnancy and at term

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Levels of leptin in maternal serum, amniotic fluid, and arterial and venous cord blood: relation to neonatal and placental weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Significant increase in maternal plasma leptin concentration in induced delivery: a possible contribution of pro-inflammatory cytokines to placental leptin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Leptin in pregnancy: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Longitudinal analysis of maternal serum leptin levels during pregnancy, at birth and up to six weeks after birth: relation to body mass index, skinfolds, sex steroids and umbilical cord blood leptin levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Suppression of leptin receptor messenger ribonucleic acid and leptin responsiveness in the ventromedial nucleus of the hypothalamus during pregnancy in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Identification of a placental enhancer for the human leptin gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Leptin in relation to growth and developmental processes in the fetus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Peripartum serum leptin and soluble leptin receptor levels in women with gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Increased plasma leptin in gestational diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Maternal plasma leptin levels and their relationship to insulin and glucose in gestational-onset diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Midtrimester amniotic fluid leptin and insulin levels and subsequent gestational diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Relative hypoleptinaemia in women with mild gestational diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Do adiponectin, TNFalpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Adipokines in inflammation and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Placental leptin receptor isoforms in normal and pathological pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Augmented placental production of leptin in preeclampsia: possible involvement of placental hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Differential placental gene expression in severe preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Increased visfatin and leptin in pregnancies complicated by pre-eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

A longitudinal study of biochemical variables in women at risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Relation between first trimester maternal serum leptin levels and body mass index in normotensive and pre-eclamptic pregnancies--role of leptin as a marker of pre-eclampsia: a prospective case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Reduced placental perfusion causes an increase in maternal serum leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Transcriptional effect of hypoxia on placental leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Serum leptin levels and uterine Doppler flow velocimetry at 20 weeks' gestation as markers for the development of pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Serum leptin levels and the severity of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Adipokines and insulin resistance during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Increased oxidative stress in obesity and its impact on metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Adipocytokines and the metabolic complications of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Cord plasma adiponectin: a 20-fold rise between 24 weeks gestation and term

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Maternal serum adiponectin multimers in gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Decreased high-molecular-weight adiponectin in gestational diabetes: implications for the pathophysiology of Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Adiponectin is present in cord blood but is unrelated to birth weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Screening for biomarkers predictive of gestational diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

First-trimester prediction of gestational diabetes mellitus: examining the potential of combining maternal characteristics and laboratory measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Adiponectin concentrations in maternal serum: elevated in preeclampsia but unrelated to insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Peripheral blood concentrations of adiponectin, an adipocyte-specific plasma protein, in normal pregnancy and preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Paradoxical Elevation in Adiponectin Concentrations in Women With Preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Adiponectin and insulin resistance in early- and late-onset pre-eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Circulating high-molecular-weight adiponectin is upregulated in preeclampsia and is related to insulin sensitivity and renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Selective increase in high molecular weight adiponectin concentration in serum of women with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

High molecular weight adiponectin dominates in cord blood of newborns but is unaffected by pre-eclamptic pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Resistin: a hormone which induces insulin resistance is increased in normal pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

High resistin and interleukin-6 levels are associated with gestational diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Increased resistin blood levels are not associated with insulin resistance in patients with renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Maternal visfatin concentration in normal pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Pre-B-cell colony-enhancing factor is a secreted cytokine-like protein from the human amniotic epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

The effects of pre–B-cell colony–enhancing factor on the human fetal membranes by microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

The role of adipocytokines in insulin resistance in normal pregnancy: visfatin concentrations in early pregnancy predict insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Serum levels of the adipokine visfatin are increased in pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Maternal and neonatal circulating visfatin concentrations in patients with pre-eclampsia and a small-for-gestational age neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Retinol binding protein 4: an adipokine associated with intra-amniotic infection/inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Retinol-binding protein-4 is not strongly associated with insulin sensitivity in normal pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Elevated level of serum retinol-binding protein 4 in pregnancy-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Serum retinol-binding protein 4 (RBP4) and retinol in a cohort of borderline obese women with and without gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Alterations in serum adipocyte fatty acid binding protein and retinol binding protein-4 in normal pregnancy and preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Preliminary report: Serum levels of retinol-binding protein 4 in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Retinol-binding protein 4 and insulin resistance in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

A novel adipocytokine, visceral adipose tissue-derived serine protease inhibitor (vaspin), and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Preliminary report: circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

Molecular Characteristics of Serum Visfatin and Differential Detection by Immunoassays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04234.X

10.1111/J.1365-2265.2011.04234.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21951069